Cannabics Pharmaceuticals Liabilities 2024

Cannabics Pharmaceuticals Aktienanalyse

What does Cannabics Pharmaceuticals do?

Cannabics Pharmaceuticals Inc. is a global company that specializes in the development of personalized therapies using medical cannabis. The company was founded in Israel in 2010 and is headquartered in Tel Aviv. Since then, the company has become a leading player in the medical cannabis industry and has expanded to the United States and Europe. The company's history began with a groundbreaking discovery by the founder's team, who found a method for isolating cannabinoids from cannabis and discovered that cannabinoids have the potential to kill tumor cells. This discovery became the company's passion and they began to focus on the production of personalized therapies using medical cannabis. Cannabics' business model consists of three main divisions: research and development, manufacturing, and commercial distribution of medical cannabis. The company is able to develop personalized therapies that take into account the specific needs of each patient by following a comprehensive approach that considers the specific needs of each patient. Cannabics' research and development department focuses on the development of new personalized therapies and medical devices that include cannabis components. This includes clinical studies to demonstrate the efficacy and safety of cannabis-based medications. The company also works closely with renowned research and development institutions to leverage the latest research and technology. The manufacturing of medical cannabis is another important division of Cannabics. The company operates as a supplier, producing high-quality, personalized cannabis oil specifically tailored to meet the patient's needs. Cannabics works with various strains and cannabis extracts to ensure that each formulation contributes to symptom relief and is safe and effective. Commercial distribution is the third pillar of Cannabics' business model. The company aims to provide its personalized therapies through pharmacies and direct distribution channels to ensure that they reach patients worldwide. Cannabics offers a variety of products, including personalized doses of medical cannabis oil, specific terpene profiles, capsules, extracts, and orally administered medications. The company also offers cannabis tests that are specifically tailored for profiling cancer cells and enabling specific personalization. In recent years, the company has focused on the development of personalized therapies for the treatment of cancer. One of its notable developments is the "Cannabics SR" platform, which provides personalized treatment options for each individual patient based on their cancer genetics. The platform consists of a diagnostic tool to determine the patient's individual cancer and tumor profile. Based on these analyses, the company then formulates a tailored medical treatment using different cannabinoids. Overall, Cannabics Pharmaceuticals Inc. has become a leading company in the medical cannabis industry. The company places a strong emphasis on research and development to develop personalized therapies for the treatment of cancer and other medical conditions and to distribute them worldwide. Cannabics Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Cannabics Pharmaceuticals's Liabilities

Cannabics Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cannabics Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Cannabics Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Cannabics Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Cannabics Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Cannabics Pharmaceuticals stock

What is the level of liabilities of Cannabics Pharmaceuticals this year?

Cannabics Pharmaceuticals has a debt balance of 2.52 M USD this year.

What were the liabilities of Cannabics Pharmaceuticals compared to the previous year?

The liabilities of Cannabics Pharmaceuticals have increased by 3.28% increased compared to the previous year.

What are the consequences of high debt for investors of Cannabics Pharmaceuticals?

High liabilities can pose a risk for investors of Cannabics Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Cannabics Pharmaceuticals?

Low liabilities mean that Cannabics Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Cannabics Pharmaceuticals affect the company?

An increase in liabilities of Cannabics Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Cannabics Pharmaceuticals affect the company?

A decrease in the liabilities of Cannabics Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Cannabics Pharmaceuticals?

Some factors that can influence the liabilities of Cannabics Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Cannabics Pharmaceuticals so important for investors?

The liabilities of Cannabics Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Cannabics Pharmaceuticals take to modify the liabilities?

To change its liabilities, Cannabics Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Cannabics Pharmaceuticals pay?

Over the past 12 months, Cannabics Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cannabics Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Cannabics Pharmaceuticals?

The current dividend yield of Cannabics Pharmaceuticals is .

When does Cannabics Pharmaceuticals pay dividends?

Cannabics Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cannabics Pharmaceuticals?

Cannabics Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Cannabics Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cannabics Pharmaceuticals located?

Cannabics Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cannabics Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cannabics Pharmaceuticals from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Cannabics Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Cannabics Pharmaceuticals in the year 2023?

In the year 2023, Cannabics Pharmaceuticals distributed 0 USD as dividends.

In which currency does Cannabics Pharmaceuticals pay out the dividend?

The dividends of Cannabics Pharmaceuticals are distributed in USD.